Shannon R Joseph 30th Lorne Cancer Conference 2018

Abstracts this author is presenting:

• CESTEM-1 clinical trials using dynamin inhibitors to reverse resistance to monoclonal antibody therapy — Session 4 - Oncogene/Tumour Targeting